Edition:
India

People: Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

17.53USD
10:38pm IST
Change (% chg)

$-0.21 (-1.18%)
Prev Close
$17.74
Open
$17.74
Day's High
$17.74
Day's Low
$17.28
Volume
6,461
Avg. Vol
19,158
52-wk High
$38.48
52-wk Low
$16.26

Mattsson, Jan 

Dr. Jan P. Mattsson Ph.D. is the Chief Scientific Officer of Albireo Pharma Inc. Dr. Mattsson has served as our Chief Scientific Officer since January 2019 and previously served as our Chief Operating Officer from November 2016 until January 2019. Dr. Mattsson is a co-founder of Albireo and has served as Chief Operating Officer of Albireo AB since February 2010, as Managing Director of Albireo AB since March 2008, as a director of Albireo AB since May 2008 and as Managing Director and a director of Elobix AB since November 2013. Previously, he served as Vice President of Operations of Albireo AB from February 2008 to February 2010, as Chief Operating Officer of Albireo Limited from February 2010 until November 2016 and as a director of Albireo Limited from February 2008 to April 2015. Prior to co-founding Albireo, Dr. Mattsson served as Associate Director at AstraZeneca. Dr. Mattsson holds a Bachelor's degree in Chemistry and a Ph.D. in Biochemistry from University of Gothenburg.

Basic Compensation

Total Annual Compensation, USD 279,016
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,125,260
Fiscal Year Total, USD 1,404,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Chiswell

195,084

Ronald Cooper

3,618,630

Simon Harford

--

Jan Mattsson

1,404,280

Martha Carter

1,243,480

Patrick Horn

--
As Of  31 Dec 2018